Pacific Biosciences of California PACB Service and other revenue — Cost of revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's service and other revenue — cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's service and other revenue — cost of revenue?
- Pacific Biosciences of California (PACB) reported service and other revenue — cost of revenue of $4.18M in Q1 2026.
- How has Pacific Biosciences of California's service and other revenue — cost of revenue changed year-over-year?
- Pacific Biosciences of California's service and other revenue — cost of revenue increased by 10.7% year-over-year, from $3.78M to $4.18M.
- What is the long-term trend for Pacific Biosciences of California's service and other revenue — cost of revenue?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's service and other revenue — cost of revenue has grown at a 3.5% compound annual growth rate (CAGR), from $13.9M to $15.39M.
- What does service and other revenue — cost of revenue mean?
- This metric captures the direct costs incurred to deliver service and support offerings to customers, including personnel expenses, spare parts, and logistics. It serves as a measure of the operational efficiency required to maintain the company's installed base of sequencing platforms. Monitoring this cost helps assess the scalability of the service organization and its impact on overall gross margins.